Stock·NYSE·Consumer Cyclical
Royal Caribbean Cruises Ltd. (RCL)
- Market cap
- $74.27B
- P/E
- 17.73
- Dividend yield
- 1.08%
- Street target
- $355.00median of 29 analysts
- 52-week range
- $222.22 $356.39
The short version
Where RCL stands today, in four lines, and what CleaRank Financial AI makes of it.
RCL at a glance
Royal Caribbean Cruises Ltd. (RCL): Buy, 60/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($274.52 and $286.51).
- Earnings RCL beat estimates in 7 of its last 8 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $643.0M and made no open-market purchases over the last 18 months.
- Valuation P/E of 17.7 against 20.8 for the Consumer Cyclical sector: broadly in line with peers (-15%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Royal Caribbean Cruises Ltd. (RCL) Buy, with a model score of 60/100.
The analysts' outlook lifts the score most: 22 of 29 analysts rate it a buy and the median target is 27.8% above the price. Valuation holds it back most: the P/S of 4.01 is 111.1% above the sector median. The trend is mixed: RCL trades 1.15% above its 50-day average of $274.52 and 3.08% below its 200-day average of $286.51. Over the past year the price fell 6.98%.
Only on CleaRank
Figures we compute ourselves from RCL's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $277.68 is 1.2% above the 50-day simple moving average of $274.52.Price above its 200-day average ›
The price is 3.1% below the 200-day simple moving average of $286.51.50-day average above the 200-day ›
The 50-day average ($274.52) is 4.2% below the 200-day average ($286.51), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 41% of its 52-week range, between $222.22 and $356.39.
RCL share price
Pick a period: each tab shows how far RCL has moved over it, to the last close.
Today's trading
Where RCL sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 17.73 is 14.7% below the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 4.01 is 111.0% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $4.4B on revenue of $18.7B, a net margin of 23.5%.Beat estimates in most recent reports ›
RCL beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.08%, or $3.00 a share a year.
Key statistics
The headline figures for RCL.
As of October 17, 2026, RCL trades at $277.68, with a market value of $74.27B, a P/E ratio of 17.73 and a dividend yield of 1.08%.
What the numbers say
CleaRank Financial AI's reading of RCL's valuation, growth and risks.
RCL is valued at a trailing P/E of 17.73, which is 14.7% below the Consumer Cyclical median of 20.8. The peer comparison on this page calls that broadly in line with peers. On sales the picture is different: the P/S of 4.01 is 111.1% above the sector median of 1.9. To put the size in context, the company has a market value of $74.3B and trailing earnings of $15.79 per share.
Revenue grew 6.50% over the latest year, which is 0.7 percentage points behind the 7.2% median for Consumer Cyclical. Profitability shows a net margin of 23.54% and an operating margin of 27.07%. It generates a return on equity of 44.67%, above the sector median of 12.4%. It also reports debt-to-equity of 2.25 and a trailing dividend yield of 1.08% ($3.00 a share a year).
RCL's most recent quarterly report came out on July 28, 2026. The company earned $4.21 per share against an estimate of $3.98, beat the estimate by 5.78%. In the first session after the report the share price moved up 0.33%.
RCL beat the EPS estimate in 7 of its last 8 reports, though the stock still fell in the first session after 4 of those 7 beats. The January 29, 2026 report stands out among the earlier ones: a miss of 0.00%, after which the stock fell 6.17%. The consensus EPS estimate stands at $17.84 for this fiscal year and $20.44 for next, growth of 14.0% for the current year.
The 30-day standard deviation of RCL's daily returns is 2.59%. The price is 22.09% below its 52-week high of $356.39. Over the last 18 months, insider sales totalled $643.0M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
RCL against the Consumer Cyclical sector
How RCL compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-15% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 6, 2025, RCL has gained 23.1% against a gain of 36.6% for SPY.
Performance against SPY
RCL and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much RCL sells, and how much of it becomes profit.
Revenue growth: Revenue grew 8.8% in FY2025 to $17.9B, from $16.5B a year earlier.
Profit margin: The net margin was 23.9% in FY2025, up from 17.6% the year before.
Profitable: RCL earned $4.3B in FY2025.
Earnings reality check
Did RCL beat what analysts expected, and how did the stock react?
Earnings record: RCL beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 4 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 28, 2026after close | $3.98 | $4.21 | +5.78% | +0.33% | +1.00% |
| Apr 30, 2026after close | $3.20 | $3.60 | +12.50% | +0.68% | +6.49% |
| Jan 29, 2026after close | $2.80 | $2.80 | +0.00% | -6.17% | -5.75% |
| Oct 28, 2025after close | $5.68 | $5.75 | +1.23% | -4.40% | -12.14% |
| Jul 29, 2025after close | $4.08 | $4.38 | +7.35% | -0.96% | -6.88% |
| Apr 29, 2025after close | $2.53 | $2.71 | +7.11% | -0.77% | +4.16% |
| Jan 28, 2025after close | $1.50 | $1.63 | +8.67% | +1.45% | -0.63% |
| Oct 29, 2024after close | $5.03 | $5.20 | +3.38% | -0.83% | +0.32% |
As of October 17, 2026, RCL has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on July 28, 2026, came in 5.78% above the estimate and the stock moved +0.33% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 54.8, in neutral territory.RSI above 50 ›
An RSI of 54.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of RCL
The score, the reasoning behind it, and what could move the price next.
RCL is caught between its two moving averages. At $277.68, the stock sits 3.08% below its 200-day average of $286.51 but 1.15% above its 50-day average of $274.52. That leaves the longer-term picture unresolved: the 50-day average is still 4.19% below the 200-day, so the slower trend has not turned up, even though the price has climbed back over the shorter average. Across its 52-week range, running from $222.22 to $356.39, the price currently sits at 41%.
Recent gains sit against a weaker longer record: the price rose 9.36% over the past month, fell 3.23% over the past three months and fell 6.98% over the past year. On momentum, the 14-day RSI reads 54.8, in the neutral zone, with the MACD line positive.
Earnings beat ›
The July 28, 2026 report beat the EPS estimate by 5.78%, and the share price rose 0.33% in the first session after it.
Source: Earnings report, July 28, 2026Analyst upgrade ›
Jefferies upgraded it to Buy from Hold on October 8, 2026.
Source: Analyst action, Jefferies, October 8, 2026Analyst upgrade ›
Deutsche Bank upgraded it to Buy from Hold on September 28, 2026.
Source: Analyst action, Deutsche Bank, September 28, 2026
No risks flagged.
- Keep an eye on the two closest levels: the 200-day SMA at $286.51 overhead and the 50-day SMA at $274.52 underneath.
- The 14-day RSI stands at 54.8, which is neutral, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- The share price gained 0.33% in the first session after the July 28, 2026 report. Over the last 8 reports, RCL has beaten estimates in 7 of them.
RCL has a mixed trend. The price is above its 50-day average of $274.52 but below its 200-day average of $286.51. Closing above the 200-day would flip both signals to up, while closing below the 50-day would flip both to down. For now, the price is wedged between the 50-day SMA ($274.52) below and the 200-day SMA ($286.51) above.
Technical indicators
Momentum and trend for RCL, from its daily closes.
As of October 17, 2026, with RCL at $277.68, its 14-day RSI is 54.8 (neutral territory), its 50-day simple moving average is $274.52 and its 200-day is $286.51.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What RCL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, RCL's 1-year correlation of daily returns is +0.58 with S&P 500 (SPY), +0.51 with Nasdaq 100 (QQQ), +0.06 with Bitcoin (BTC) and +0.06 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
22 of 29 analysts rate it a buy or strong buy, 7 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $355.00 is 27.8% above the price.More buy ratings than three months ago ›
22 of 29 rate it a buy now, against 19 of 28 three months ago.
RCL Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | Jefferies | Upgrade | Buy |
| Oct 7, 2026 | Barclays | Maintains | Overweight |
| Sep 28, 2026 | Tigress Financial | Maintains | Buy |
| Sep 28, 2026 | Deutsche Bank | Upgrade | Buy |
| Sep 24, 2026 | Truist Securities | Maintains | Hold |
| Sep 24, 2026 | JP Morgan | Maintains | Overweight |
As of October 17, 2026, 29 Wall Street analysts cover RCL: 22 rate it a buy or strong buy, 7 a hold and 0 a sell or strong sell. Their 12-month price targets range from $262.00 to $425.00, with a median of $355.00, 27.8% above the price of $277.68.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
RCL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from RCL's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much RCL tends to move, against the market and on its own.
The long record
RCL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 2.59% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 83.0%, from December 2019 to March 2020, regained by March 2024.Most 1-year holds ended higher ›
62% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $45,307, against $42,055 in the S&P 500 (SPY).
RCL Drawdowns & Recovery
As of October 17, 2026, RCL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -83.0% (December 2019 to March 2020); it regained that peak by March 2024, 48 months after the low, and 62% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RCL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: RCL beat the S&P 500 over this period: $45,307 against $42,055.
A $10,000 investment in RCL in October 2016 would be worth about $45,307 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RCL, and which have not.
Strongest month, November: an average of +11.23%, up in 8 of 10 years.
Weakest month, March: an average of -9.16%, up in 2 of 10 years.
This month, October: has averaged -1.69%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, RCL's strongest calendar month has been November (average +11.23%, up in 8 of 10 years) and its weakest March (average -9.16%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RCL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in RCL today could grow to about $24,167 by 2036 in the base case, with a 90th-percentile outcome near $183,349 and a 10th-percentile outcome around $3,186. The simulation models price only; at today's 1.08% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
RCL Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $395 for RCL by 2030 in the base case, from $278 today (1.4x over 4 years). The 10th-percentile path ends near $110. These are outcomes of a Monte Carlo simulation run on RCL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $160 | $303 | $576 | |
| 2028 | $134 | $331 | $820 | |
| 2029 | $119 | $362 | $1,098 | |
| 2030 | $110 | $395 | $1,424 | |
| 2031 | $103 | $432 | $1,809 |
Method: a lognormal simulation of RCL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. RCL is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
RCL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought RCL shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, RCL insiders reported 18 open-market sales worth $643.0M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Michael W Bayley
Officer
|
Sell | 12.8K | $4.0M |
| May 28, 2026 | John F Brock
Director
|
Grant | 831 | - |
| May 28, 2026 | Richard David Fain
Director
|
Grant | 831 | - |
| May 28, 2026 | Stephen R. Howe Jr
Director
|
Grant | 831 | - |
| May 28, 2026 | Michael O Leavitt
Director
|
Grant | 831 | - |
| May 28, 2026 | Amy C. Mcpherson
Director
|
Grant | 831 | - |
| May 28, 2026 | Maritza Gomez Montiel
Director
|
Grant | 831 | - |
| May 28, 2026 | Eyal Ofer
Director
|
Grant | 831 | - |
| May 28, 2026 | Vagn O Sorensen
Director
|
Grant | 831 | - |
| May 28, 2026 | Donald Thompson
Director
|
Grant | 831 | - |
| May 28, 2026 | Christopher J. Wiernicki
Director
|
Grant | 571 | - |
| May 28, 2026 | Christopher J. Wiernicki
Director
|
Grant | 831 | - |
| May 28, 2026 | Arne Alexander Wilhelmsen
Director
|
Grant | 831 | - |
| Feb 27, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 771.6K | $243.6M |
| Feb 27, 2026 | Christopher J. Wiernicki
Director
|
Grant | 444 | - |
| Feb 24, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 473.5K | $149.4M |
| Feb 19, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 206.4K | $65.4M |
| Feb 17, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 280.0K | $91.2M |
| Feb 17, 2026 | Laura H Bethge
Officer
|
Sell | 7.9K | $2.6M |
| Feb 17, 2026 | Maritza Gomez Montiel
Director
|
Sell | 1.4K | $453.1K |
| Feb 13, 2026 | Jason T Liberty
Chief Executive Officer
|
Sell | 90.9K | $29.7M |
| Feb 13, 2026 | Michael W Bayley
Officer
|
Sell | 80.0K | $26.1M |
| Feb 13, 2026 | Naftali Holtz
Chief Financial Officer
|
Sell | 51.1K | $16.7M |
| Feb 13, 2026 | Henry L Pujol
Officer
|
Sell | 4.4K | $1.5M |
| Feb 13, 2026 | Naftali Holtz
Chief Financial Officer
|
Grant | 750 | - |
| Feb 10, 2026 | Michael W Bayley
Officer
|
Grant | 173.7K | - |
| Feb 10, 2026 | Laura H Bethge
Officer
|
Grant | 35.0K | - |
| Feb 10, 2026 | Naftali Holtz
Chief Financial Officer
|
Grant | 66.0K | - |
| Feb 10, 2026 | Harri U Kulovaara
Officer
|
Grant | 45.1K | - |
| Feb 10, 2026 | Robert Alexander Lake
Officer
|
Grant | 30.5K | - |
| Feb 10, 2026 | Jason T Liberty
Chief Executive Officer
|
Grant | 296.3K | - |
| Feb 10, 2026 | Henry L Pujol
Officer
|
Grant | 11.4K | - |
| Dec 23, 2025 | Richard David Fain
Director
|
Grant | 17.6K | - |
| Nov 3, 2025 | Maritza Gomez Montiel
Director
|
Sell | 1.1K | $309.9K |
| Oct 2, 2025 | John F Brock
Director
|
Grant | 3.2K | - |
| Aug 19, 2025 | Vagn O Sorensen
Director
|
Sell | 10.3K | $3.4M |
| Aug 6, 2025 | Richard David Fain
Director
|
Sell | 16.0K | $5.0M |
| Jul 30, 2025 | Henry L Pujol
Officer
|
Sell | 5.2K | $1.7M |
| Jun 27, 2025 | Robert Alexander Lake
Officer
|
Sell | 2.9K | $860.3K |
| Jun 6, 2025 | Robert Alexander Lake
Officer
|
Sell | 2.5K | $687.5K |
| May 28, 2025 | John F Brock
Director
|
Grant | 870 | - |
| May 28, 2025 | Richard David Fain
Director
|
Grant | 870 | - |
| May 28, 2025 | Stephen R. Howe Jr
Director
|
Grant | 870 | - |
| May 28, 2025 | Michael O Leavitt
Director
|
Grant | 870 | - |
| May 28, 2025 | Amy C. Mcpherson
Director
|
Grant | 870 | - |
| May 28, 2025 | Maritza Gomez Montiel
Director
|
Grant | 870 | - |
| May 28, 2025 | Ann S Moore
Director
|
Grant | 870 | - |
| May 28, 2025 | Eyal Ofer
Director
|
Grant | 870 | - |
| May 28, 2025 | Vagn O Sorensen
Director
|
Grant | 870 | - |
| May 28, 2025 | Donald Thompson
Director
|
Grant | 870 | - |
| May 28, 2025 | Arne Alexander Wilhelmsen
Director
|
Grant | 870 | - |
| May 28, 2025 | Rebecca Yeung
Director
|
Grant | 870 | - |
| May 12, 2025 | Maritza Gomez Montiel
Director
|
Sell | 1.5K | $363.7K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.